C. Wedelin

发表

Prognostic factors in hodgkin's disease with special reference to age

P. Biberfeld, M. Björkholm, G. Holm, 1984, Cancer.

A population-based cohort study on early-stage Hodgkin lymphoma treated with radiotherapy alone: with special reference to older patients.

T. Fears, M. Björkholm, O. Landgren, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long‐term follow‐up

M. Björkholm, G. Holm, H. Mellstedt, 1991, Cancer.

Blood T-lymphocyte functions in healthy adults in relation to age.

M. Björkholm, S. Ogenstad, G. Holm, 2009, Scandinavian journal of haematology.

Mab 17-1A Used for Therapy of Patients with Metastatic Colorectal Carcinomas

B. Ahlman, J. Shetye, U. Harmenberg, 1989 .

Familial longevity and prognosis in Hodgkin's disease

M. Björkholm, G. Holm, C. Wedelin, 1984, Cancer.

Clinical and laboratory findings in untreated patients with Hodgkin’s disease with special reference to age

M. Björkholm, H. Mellstedt, B. Johansson, 1984, Medical oncology and tumor pharmacotherapy.

Monoclonal antibodies (MAb 17-1A) for the treatment of patients with metastatic colorectal carcinomas.

J. Shetye, P. Biberfeld, B. Christensson, 1989, Acta chirurgica Scandinavica. Supplementum.

Biologic response modifiers in the treatment of gastrointestinal malignancies.

M. Steinitz, C. Lindemalm, P. Wersäll, 1989, Scandinavian journal of gastroenterology.

A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia.

J. Palmblad, E. Kimby, G. Gahrton, 1991, Leukemia & lymphoma.

A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas.

L. Skoog, M. Czader, M. Björkholm, 2004, The hematology journal : the official journal of the European Haematology Association.

Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.

M. Björkholm, S. Ogenstad, G. Holm, 1982, British Journal of Cancer.

Routine laboratory tests in relation to spleen size and tumour involvement in untreated Hodgkin's disease.

M. Björkholm, J. Askergren, G. Holm, 2009, Acta medica Scandinavica.

Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III —A randomized study from MGCS

H. Strander, E. Kimby, B. Johansson, 1989, European journal of haematology.

High doses of natural α‐interferon (α‐IFN) in the treatment of multiple myeloma — A pilot study from the Myeloma Group of Central Sweden (MGCS)

G. Gahrton, G. Juliusson, M. Björkholm, 1988 .

Immune status of untreated patients with Hodgkin's disease and prognosis.

M. Björkholm, S. Ogenstad, G. Holm, 1982, Cancer treatment reports.

Clinical findings and prognostic factors in chronic myeloid leukemias.

G. Gahrton, M. Björkholm, G. Holm, 2009, Acta medica Scandinavica.

Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis.

M. Björkholm, B. Nilsson, O. Landgren, 2003, Haematologica.

Blood lymphocyte functions in relation to splenic weight and tumor involvement in untreated Hodgkin's disease.

M. Björkholm, J. Askergren, G. Holm, 2009, Scandinavian journal of haematology.

Longitudinal studies of blood lymphocyte capacity in Hodgkin's disease

M. Björkholm, G. Holm, H. Mellstedt, 1981, Cancer.

Lymphocytotoxic serum factors and lymphocyte functions in untreated Hodgkin'S disease

M. Björkholm, G. Holm, H. Mellstedt, 1982, Cancer.